Marshall Wace, LLP Magenta Therapeutics, Inc. Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.41 - $0.86 $64,644 - $135,596	157,670 New	157,670 $124,000
Q2 2021 Aug 13, 2021	BUY	$9.76 - $14.15 $146,195 - $211,952	14,979 New	14,979 $146,000
Q1 2021 May 17, 2021	SELL	$7.66 - $13.38 $559,279 - $976,913	-73,013 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$6.52 - $8.94 $562,024 - $770,628	-86,200 Reduced 54.14%	73,013 $496,000
Q2 2020 Aug 13, 2020	BUY	$6.18 - $10.76 $983,936 - $1.71 Million	159,213 New	159,213 $1.2 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.